Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Drug Cocktails for Cancer, Heart Disease Get Streamlined Review From FDA
Bloomberg
Tue, 12/14/10 - 05:34 pm
FDA
Roche
Sanofi
drug cocktails
cancer
Novartis
Pfizer
GSK
Merck
heart disease
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Seeking Alpha
Tue, 12/14/10 - 11:04 am
FDA
major depressive disorder
Forest Labs
GSK
Eli Lilly
Merck
Clinical Data
Vilazodone
Pfizer
Big Pharma's Lost Stock Market Decade
Seeking Alpha
Mon, 12/13/10 - 08:32 pm
Big Pharma
Abbott Laboratories
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
How Cheap Is Merck's Stock by the Numbers?
Motley Fool
Mon, 12/13/10 - 10:06 am
Merck
Frudakis vs. Merck Pharmaceutical Complaint Against Merck for Failing to Pay Drug Sales Reps Overtime
JD Supra
Sat, 12/11/10 - 12:49 pm
Merck
overtime lawsuits
Merck Closes on $2 Billion Notes Sale
The Street
Sat, 12/11/10 - 12:07 pm
Merck
Moaning at Merck: Sales Reps Get New Cars — Free! — and Many Hate It
BNET Pharma
Fri, 12/10/10 - 11:38 am
Merck
drug reps
layoffs
Bayer, Boehringer, Novartis vie for vet ops-sources
Reuters
Thu, 12/9/10 - 08:22 pm
animal health
Bayer
Boehringer Ingelheim
Novartis
Merck
Sanofi
A Tale of Two Pharmas: Outlooks for Lilly and Merck
Seeking Alpha
Thu, 12/9/10 - 12:10 pm
Eli Lilly
Merck
Pharmaceuticals Pregnant and Overdue
Seeking Alpha
Wed, 12/8/10 - 02:14 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
JNJ
Merck
Mylan
Pfizer
Can New Leadership Rejuvenate Big Pharma?
Investopedia
Wed, 12/8/10 - 12:25 pm
AstraZeneca
GSK
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Merck Plans Bond Sale of Up to $2.5 Billion After S&P Boosts Credit Rating
Bloomberg
Tue, 12/7/10 - 11:41 am
Merck
bonds
Merck Makes Insulin Play: Biotech Transactions Heat Up
Seeking Alpha
Sun, 12/5/10 - 11:58 am
Merck
SmartCells
insulin
diabetes
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
GSK
Merck
Avodart
enlarged prostate
prostate cancer
Proscar
Orexigen
obesity
Contrave
Novartis
JNJ
Merck KGaA
Pharma Mergers Scrutinized In Insider Trading Probe
Reuters
Fri, 12/3/10 - 08:24 am
M&A
insider trading
MedImmune
AstraZeneca
Wyeth
Pfizer
Merck
Schering Plough
Alnylam says it won Europe RNA patent dispute
Yahoo/AP
Fri, 12/3/10 - 06:44 am
patents
Alnylam
RNA
gene silencing
Merck
Pfizer
Sima
Merck & Co. buying SmartCells for $500 million
Marketwatch
Thu, 12/2/10 - 09:20 am
SmartCells
M&A
Merck
diabetes
Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wed, 12/1/10 - 05:55 pm
Merck
Proscar
FDA
prostate cancer
Incoming Merck chief to focus on pricing
FT.com
Wed, 12/1/10 - 07:18 am
Merck
Pharma CEOs
pricing
Kenneth Frazier
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »